Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Low-Level Laser Therapy Induces Melanoma Tumor Growth by Promoting Angiogenesis

Our findings indicate that LLLT induces melanoma tumor growth by promoting angiogenesis. Therefore, it should be avoided in patients with melanoma.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied mice with B16F10 melanoma treated with low-level laser therapy for five days, plus laboratory experiments on melanoma cells. They report that treated mice had greater tumor weight and higher levels of the blood vessel marker CD31 than untreated controls, and that laser exposure activated ERK and p38 signaling and increased vascular endothelial growth factor in cells. The authors conclude that the therapy promotes tumor growth through angiogenesis and should be avoided in patients with melanoma.

Who or what was studied
C57/BL6 mice challenged with B16F10 melanoma cells, plus B16F10 cells in vitro
Limits stated in the abstract
The abstract does not report the wavelength, dose, or sample size, and the evidence comes from a mouse model and cell experiments rather than human patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The effects of low-level laser therapy (LLLT) on tumor growth are inconsistent. In this study, we investigated the effects of LLLT on melanoma tumor growth and angiogenesis. C57/BL6 mice were challenged with B16F10 melanoma cells and treated with LLLT for 5 consecutive days; untreated mice were used as controls. Tumor weight, angiogenesis, immunohistochemistry, and protein levels were compared between the treated and untreated mice. In an in vitro experiment, B16F10 cells were treated with LLLT. Proteins were extracted and subjected to Western blot analysis for analyzing signaling pathways. Compared with the findings in the untreated mice, tumor weight substantially increased in the treated mice. Both immunohistochemical and Western blot analyses revealed markedly increased levels of CD31, a biomarker of vascular differentiation, in the LLLT group. In B16F10 cells, LLLT considerably induced the phosphorylation of extracellular signal-regulated kinase (ERK), which, in turn, phosphorylated p38 mitogen-activated protein kinase (MAPK). Furthermore, LLLT induced the expression of vascular endothelial growth factor, but not hypoxia-inducible factor-1α, through the ERK/p38 MAKP signaling pathways. Our findings indicate that LLLT induces melanoma tumor growth by promoting angiogenesis. Therefore, it should be avoided in patients with melanoma.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Low-level laser therapy, Angiogenesis, Laser, Biomarker. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies